appointments

Sales & Marketing

Changing Faces May-June 2024: Agency, consultancy, and inves...

For a super-sized hires round-up, our list of hires in the agency and consultancy world for May and June is surprisingly concise.

Digital

Changing Faces: May and June 2024 supplier and digital hires

In the pharma-adjacent, pharma supplier, and digital health worlds, we saw a significant number of hires in May and June.

R&D

Changing Faces – Pharma and biotech May and June 2024

Welcome back to another edition of Changing Faces.

News

Merdad Parsey will leave Gilead next year

Gilead Sciences' chief medical officer, Merdad Parsey, will leave the company in early 2025, becoming the latest in a series of high-profile departures involving senior R&D figures at t

News

AbbVie's new chief scientific officer Roopal Thakkar (l), who is replacing Thomas Hudson (r)

AbbVie lines up Thakkar to replace outgoing CSO Hudson

There is change at the top of AbbVie’s R&D organisation, as chief scientific officer Thomas Hudson announces his retirement after four years in the role.

News

Mikael Dolsten exits Pfizer, putting R&D leadership in flux

Pfizer’s chief scientific officer and president of R&D, Mikael Dolsten, has said he will step down from the role in the coming months, kicking off the search for a successor.

Changing Faces May-June 2024: Agency, consultancy, and inves...

Changing Faces: May and June 2024 supplier and digital hires

Changing Faces – Pharma and biotech May and June 2024

Merdad Parsey will leave Gilead next year

AbbVie lines up Thakkar to replace outgoing CSO Hudson

Mikael Dolsten exits Pfizer, putting R&D leadership in flux

Senju launches first-in-class dry eye disease drug in Japan

Using AI-driven synthetic personas to take your insights fur...

appointments

Editor's Picks